Charles Ferté

VP, Global Medical Lead

Dr. Charles Ferté has over 15 years of R&D experience in oncology drug development, both in academia and industry. Having held multiple roles at AstraZeneca, Charles most recently served as senior director and global project leader in AstraZeneca’s oncology R&D division where he oversaw the development of multiple immune-oncology assets. Before AstraZeneca, Charles was a physician scientist at the Institute Gustave Roussy (IGR) in Paris, France, working as a senior attending medical oncologist in the Early Drug Development (DITEP), GI and Head and Neck units. Charles has served as co-chair of the iRECIST group, part of the official RECIST working group, since 2019, and has co-authored 60+ patents and publications in peer-reviewed journals across multiple oncology disease areas.

Charles holds an M.D. from Paris V and Lille II Universities and a Ph.D. in cancer biology from Paris-Sud University.

Roles at Relay Therapeutics

  • VP, Global Medical Lead

    April, 2021 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Relay Therapeutics

My pet peeves

My communication style

Org chart

Direct reports

No reports


No teams